This study aims to evaluate the efficacy and safety of combining PCSK9 inhibitors with statins compared to statin monotherapy in preventing early neurological deterioration (END) in acute ischemic stroke (AIS) patients with a history of coronary heart disease (CHD). The gene discussed is PCSK9; the disease is androgen insensitivity syndrome.